ETF comparison
FHLCvsXLV
Both Healthcare.
Fidelity MSCI Health Care Index ETF · State Street Health Care Select Sector SPDR ETF
Holdings overlap
60 positions appear in both funds. Buying equal dollars of FHLC and XLV would leave roughly84.4%of each dollar exposed to the same underlying securities.
Side by side
Sub-score comparison
Tracking quality isn't part of the composite — seewhat we don't scorefor why.
Cost difference
Expense ratios are effectively identical (0.084% vs 0.080%).
Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with FHLC vs XLV.
Top shared holdings
60 shared in total| # | Holding | In FHLC | In XLV | Overlap |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 12.13% | 16.51% | 12.13% |
| 2 | Johnson & Johnson | 8.94% | 10.64% | 8.94% |
| 3 | AbbVie Inc | 6.03% | 7.74% | 6.03% |
| 4 | UnitedHealth Group Inc | 5.42% | 6.57% | 5.42% |
| 5 | Merck & Co Inc | 4.38% | 5.52% | 4.38% |
| 6 | Amgen Inc | 3.01% | 3.40% | 3.01% |
| 7 | Thermo Fisher Scientific Inc | 2.91% | 3.24% | 2.91% |
| 8 | Gilead Sciences Inc | 2.62% | 2.73% | 2.62% |
| 9 | Abbott Laboratories | 2.55% | 2.75% | 2.55% |
| 10 | Intuitive Surgical Inc | 2.62% | 2.45% | 2.45% |
| 11 | Pfizer Inc | 2.45% | 2.39% | 2.39% |
| 12 | Bristol-Myers Squibb Co | 1.99% | 2.05% | 1.99% |
Only in FHLC
278 total- Alnylam Pharmaceuticals Inc0.66%
- Insmed Inc0.47%
- Natera Inc0.44%
- United Therapeutics Corp0.38%
- Revolution Medicines Inc0.38%
- Royalty Pharma PLC0.33%
- Illumina Inc0.31%
- Tenet Healthcare Corp0.25%
- State Street Global Advisors0.23%
- Neurocrine Biosciences Inc0.21%
Only in XLV
1 total- State Street Global Advisors0.01%
Open FHLC or XLV at a brokerage
Both funds trade commission-free at major US brokerages.
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.
Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.
Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.